"It looks like there is no case at all to be made for some of these therapies, and for remdesivir, it looks like the argument now is “Does it help a bit or just

"It looks like there is no case at all to be made for some of these therapies, and for remdesivir, it looks like the argument now is “Does it help a bit or just not at all?” The only thing that I’ve seen that really seems to be making a big difference now is dexamethasone, and we may soon (I hope) be adding the monoclonal antibodies to that list. The SOLIDARITY enrollment is still moving along at 2000 patients/month, and will be looking at these and other newer ideas as it continues. And that means abandoning the older ideas, because – as we’re finding out – they’re not much help. It’s time to move on." Just so everyone knows, this is the same guy that writes the 'Things I Won't Work With" blog. It's all about insane chemical compounds and is very much one of the best blogs ever written. https://blogs.sciencemag.org/pipeline/?s=things+I+won%27t+work+with https://blogs.sciencemag.org/pipeline/?s=things+I+won%27t+wo...